The DOI matches its Crossref record; the references it cites are not checked yet.
A wealth of discovery built on the Human Genome Project — by the numbers
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The availability of many human genes for experimental analysis, combined with research drivers that favour the continued investigation of genes of known function (57, 58, 59), may unwittingly provide an extensive source of topics around which gene research articles can be fraudulently created (8, 24).”
From Identification of human gene research articles with wrongly identified nucleotide sequences (2022) · cites this paper as [59]
In the citing paper
“we are concerned that the number of human genes that are available for analysis, combined with research drivers that favour the continued investigation of genes of known function (57, 58, 59), are unwittingly providing an extensive source of topics around which gene research articles can be fraudulently created.”
From Identification of human gene research articles with wrongly identified nucleotide sequences (2022) · cites this paper as [59]
In the citing paper
“Instead, well-characterized genes continue to be preferentially studied, due to reagent availability, researcher unwillingness or difficulties in changing research focus, and possible career penalties for investigating under-studied human genes (17,20,23).”
From Protection of the human gene research literature from contract cheating organizations known as research paper mills (2022) · cites this paper as [20]
In the citing paper
“Although the first draft of the human genome (24,25) was expected to increase the types and numbers of human genes that were subjected to experimentation, this broadening of research focus did not occur (Figure 3) (13,15–17,20,23).”
From Protection of the human gene research literature from contract cheating organizations known as research paper mills (2022) · cites this paper as [20]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 18 · Cited by 98
Research works printed but not linked: 1
- Gysi, D. M. et al. Preprint at https://arxiv.org/abs/2004.07229 (2020). · arXiv
Metadata
- Authors
- Gates, A. J., Gysi, D. M., Kellis, M., & Barabási, A.-L.
- Affiliations
- Northeastern University (US)
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- Venue
- Nature
- Published
- 2021-02-10
- Volume
- 590
- Issue
- 7845
- Pages
- 212-215
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W3126301633
- Cited by
- 98
- References
- 18
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 15 · 2023: 32 · 2022: 24 · 2021: 13
- FWCI
- 18.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Science, Research, and Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
- Keywords
- Human Genome Project, draft genome sequence, scientific publications, drug approval, disease understanding
- MeSH terms
- Genes, Genetics, Medical, Humans, Proteins, Genome, Human, Human Genome Project, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, DNA, Intergenic, Genetic Diseases, Inborn, History, 21st Century, Drug Discovery, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A wealth of discovery built on the Human Genome Project — by the numbers. https://app.cochat.ai/papers/10.1038/d41586-021-00314-6
- The paper
- Gates, A. J., Gysi, D. M., Kellis, M., & Barabási, A.-L. (2021). A wealth of discovery built on the Human Genome Project — by the numbers. Nature. https://doi.org/10.1038/d41586-021-00314-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.